|
| |
BioPortfolio's Approved Drugs DatabaseUltramTramadol HydrochlorideDownload PDF containing detailed information.
Press Releases About Ultram:
|
 |
| Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009 |
6th November, 2009 |
Par Pharmaceutical Companies |
-- Metoprolol: For the quarter ended October 3, 2009, net sales of
metoprolol succinate were $161.1 million, a decrease of 47% from the
second quarter 2009. The decrease was
|
Companies working in the area of Ultram from Bioportfolio's Biocorporate database : |  |
| Company Name | |
SynCo Bio Partners B.V. is an ultramodern, private company (a former production facility of Chiron) based in Amsterdam, The Netherlands. The company boasts over 10 years of experience in process...
www.synco-biopartners.com/ View full profile
| |
Structure Probe, Inc. was founded in April, 1970 by Charles A. Garber, Ph. D., who is still the President and Chief Executive Officer of the firm.From the starting point of one of the first scanning...
www.2spi.com/ View full profile
| |
Belco Pharma is a WHO certified pharmaceutical company established in 1975. The company is engaged in the manufacture and sale of generic and proprietary pharmaceutical products. Belco Pharma is one...
www.belcoindia.com/ View full profile
| | →View more Ultram related companies. |
This page has been viewed 41 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Ultram across BioPortfolio, or for Ultram Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|